David Poon

David Poon is a seasoned leader in the lifesciences industry, specializing in business development within biotechnology. They currently serve as a Business Development, Strategy, and Transactions Advisor at SynapticBio Strategic Advisors Inc. and co-founded DCx Biotherapeutics Corporation. Previously, David held various senior roles at Zymeworks Inc., where they led successful global licensing deals worth over $8 billion. Their educational background includes a PhD in Chemistry from the University of British Columbia, where they also completed a BSc in Biology and Chemistry with a minor in Psychology. David actively contributes to the community as a Director at Life Sciences BC and as a Board Member at BioCanRx.